0.0 z 5 hvězdiček
pevná vazba
Bad Blood : Secrets and Lies in a Silicon Valley Startup
Kniha ( měkká vazba )
- Produkt je vyprodaný.
Při zaslání zboží balíčkem
K nákupu nad 699 Kč dárek zdarma v hodnotě 19 Kč
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup `unicorn'… Přejít na celý popis
-
159 Kč s DPH Skladem
-
455 Kč s DPH Dostupné u dodavatele
-
312 Kč s DPH Dostupné u dodavatele
-
269 Kč s DPH Ihned ke stažení
-
399 Kč s DPH Ihned ke stažení
-
357 Kč s DPH Skladem (vybrané prodejny)
-
Nedostupné
-
Nedostupné
Zobrazit více variant
(+3)
Nejkrásnější dětská kniha se vrací! Objevujte tajemství vesmíru a mimozemského života s úžasnými ilustracemi, z nichž některé svítí ve tmě!
Více informací
K tomuto produktu zákazníci kupují
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup `unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.
For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos' articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.
In Bad Blood John Carreyrou tells the story of Theranos, and encourages us to consider the possible repercussions of our blind faith in a small group of brilliant individuals.
Now to be adapted into a film, with Jennifer Lawrence to star.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup `unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.
For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos' articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.
In Bad Blood John Carreyrou tells the story of Theranos, and encourages us to consider the possible repercussions of our blind faith in a small group of brilliant individuals.
Now to be adapted into a film, with Jennifer Lawrence to star.
- Nakladatel
- Picador
- Rozměr
- 153 x 234 x 26
- jazyk
- angličtina
- Počet stran
- 339
- Vydání
- 1
- isbn
- 978-1-5098-6807-0
- Vazba
- měkká vazba
- datum vydání
- 29.05.2018
- ean
- 9781509868070
Hodnocení a recenze čtenářů Nápověda
4.4 z 5 8 hodnocení čtenářů
4× 5 hvězdiček 3× 4 hvězdičky 1× 3 hvězdičky 0× 2 hvězdičky 0× 1 hvezdička
Přidejte své hodnocení knihy
Hodnocení našich knihkupců: 0.0 z 5
-
Ondřej Kazmar registrovaný uživatel 4 z 5 hvězdiček Zakoupil produkt
Vyborná knížka četl jsem již original, tento překlad mam jen do sbírky
Přečíst více -
Jana Grillová registrovaný uživatel 5 z 5 hvězdiček
Jednoduše skvělé čtení.
Přečíst více
Vývoj ceny Nápověda
Získejte přehled o vývoji ceny za posledních 60 dní.
Maloobchodní cena
Minimální prodejní cena:
0 Kč
Nápověda
Články, které stojí za pozornost
-
-
-
-
-
-
-
-
-
-
-
-
